Position in PRCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$43,035,657
-$6,463,664 QoQ
Shares Held
1,720,738
+9.4% QoQ
Ownership
3.02%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRCT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $936,679,175 across 19 Medical Devices names. PRCT ranks #8 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
749,867 | $246,398,797 | |
| 2 | MDT |
Medtronic plc
|
2,299,782 | $199,276,110 | |
| 3 | ABT |
Abbott Laboratories
|
1,473,375 | $151,271,411 | |
| 4 | DXCM |
Dexcom Inc
|
1,203,945 | $75,607,746 | |
| 5 | NEOG |
Neogen Corp
|
7,803,226 | $72,491,969 | |
| 6 | BSX |
Boston Scientific Corp
|
959,867 | $60,231,654 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
371,475 | $43,841,479 | |
| 8 | PRCT |
PROCEPT BioRobotics Corp
This page
|
1,720,738 | $43,035,657 |
All Filings in PRCT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,035,657 | 1,720,738 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $49,499,321 | 1,573,405 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $51,908,749 | 1,454,434 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $40,818,585 | 708,656 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $227,791 | 2,829 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $216,644 | 2,704 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||